Annual Total Expenses
$164.16 M
+$33.51 M+25.65%
December 31, 2023
Summary
- As of February 7, 2025, AVIR annual total expenses is $164.16 million, with the most recent change of +$33.51 million (+25.65%) on December 31, 2023.
- During the last 3 years, AVIR annual total expenses has risen by +$104.50 million (+175.15%).
- AVIR annual total expenses is now -22.93% below its all-time high of $212.99 million, reached on December 31, 2021.
Performance
AVIR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$37.20 M
-$9.71 M-20.71%
September 30, 2024
Summary
- As of February 7, 2025, AVIR quarterly total expenses is $37.20 million, with the most recent change of -$9.71 million (-20.71%) on September 30, 2024.
- Over the past year, AVIR quarterly total expenses has dropped by -$3.58 million (-8.79%).
- AVIR quarterly total expenses is now -47.60% below its all-time high of $71.00 million, reached on December 31, 2021.
Performance
AVIR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AVIR Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.6% | -8.8% |
| 3 y3 years | +175.2% | -8.8% |
| 5 y5 years | +1632.2% | -8.8% |
AVIR Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.9% | +25.6% | -47.6% | +128.5% |
| 5 y | 5-year | -22.9% | +1023.8% | -47.6% | +819.7% |
| alltime | all time | -22.9% | +1632.2% | -47.6% | +887.0% |
Atea Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $37.20 M(-20.7%) |
| Jun 2024 | - | $46.92 M(-32.8%) |
| Mar 2024 | - | $69.81 M(+49.9%) |
| Dec 2023 | $164.16 M(+25.7%) | $46.57 M(+14.2%) |
| Sep 2023 | - | $40.78 M(+15.8%) |
| Jun 2023 | - | $35.23 M(-15.2%) |
| Mar 2023 | - | $41.57 M(+4.2%) |
| Dec 2022 | $130.65 M(-38.7%) | $39.90 M(+145.1%) |
| Sep 2022 | - | $16.28 M(-49.6%) |
| Jun 2022 | - | $32.30 M(-23.4%) |
| Mar 2022 | - | $42.17 M(-40.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $212.99 M(+257.0%) | $71.00 M(+29.2%) |
| Sep 2021 | - | $54.96 M(+6.3%) |
| Jun 2021 | - | $51.70 M(+46.3%) |
| Mar 2021 | - | $35.33 M(+26.2%) |
| Dec 2020 | $59.66 M(+308.4%) | $27.99 M(+58.7%) |
| Sep 2020 | - | $17.63 M(+76.2%) |
| Jun 2020 | - | $10.00 M(+147.3%) |
| Mar 2020 | - | $4.04 M(-14.8%) |
| Dec 2019 | $14.61 M(+54.1%) | $4.75 M(+26.0%) |
| Sep 2019 | - | $3.77 M |
| Dec 2018 | $9.48 M | - |
FAQ
- What is Atea Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual total expenses year-on-year change?
- What is Atea Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly total expenses year-on-year change?
What is Atea Pharmaceuticals annual total expenses?
The current annual total expenses of AVIR is $164.16 M
What is the all time high annual total expenses for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual total expenses is $212.99 M
What is Atea Pharmaceuticals annual total expenses year-on-year change?
Over the past year, AVIR annual total expenses has changed by +$33.51 M (+25.65%)
What is Atea Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of AVIR is $37.20 M
What is the all time high quarterly total expenses for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly total expenses is $71.00 M
What is Atea Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, AVIR quarterly total expenses has changed by -$3.58 M (-8.79%)